5-Amino-1MQ: Dosage, Protocol, and Research Guide
NNMT inhibitor that enhances metabolic function and promotes fat loss
Mechanism
Inhibits nicotinamide N-methyltransferase (NNMT), increasing NAD+ levels and metabolic rate while reducing fat storage
Protocol at a glance
| Starting dose | 50mg |
|---|---|
| Maintenance dose | 100mg |
| Maximum dose | 150mg |
| Frequency | Daily |
| Typical duration | 8-12 weeks |
| Route | Oral |
| Injection site | N/A |
| Timing | Morning with food |
Side effects
- Mild nausea
- Increased energy
- Sleep disturbances if taken late
Contraindications
- Pregnancy
- Nursing
- Severe liver disease
Protocol notes
- Activates brown adipose tissue
- Improves insulin sensitivity
- May enhance weight loss when combined with diet and exercise
- Non-stimulant metabolic enhancer
- Monitor liver enzymes during use
Frequently asked questions
What is the correct dosing protocol for 5-Amino-1MQ?
5-Amino-1MQ is typically initiated at 50mg daily to assess tolerance. The standard maintenance dose is 100mg daily, with maximum doses reaching 150mg daily depending on individual response and goals. Dosing is administered once daily in the morning with food to optimize absorption and reduce gastrointestinal side effects. Most users follow 8-12 week cycles, followed by a break period before repeating, to maintain sensitivity to the compound and assess metabolic adaptation.
How does 5-Amino-1MQ actually work for weight loss?
5-Amino-1MQ works by inhibiting nicotinamide N-methyltransferase (NNMT), an enzyme that regulates cellular metabolism. This inhibition increases NAD+ levels, which enhances metabolic rate and energy expenditure at the cellular level. The compound also activates brown adipose tissue, metabolically active fat that burns calories for heat production. Additionally, 5-Amino-1MQ improves insulin sensitivity, supporting metabolic health and weight management. This multi-pathway approach makes it effective as a non-stimulant metabolic enhancer.
What are the side effects of 5-Amino-1MQ?
Reported side effects are generally mild and include nausea, increased energy, and sleep disturbances if taken late in the day. These effects typically resolve with consistent use and are minimized by taking the compound in the morning with food. Contraindications include pregnancy, nursing, and severe liver disease. Liver enzyme monitoring is recommended during use due to hepatic metabolism. Most users find the side effect profile manageable and report adaptation over the first 1-2 weeks.
Can I stack 5-Amino-1MQ with other supplements?
5-Amino-1MQ can potentially be incorporated into broader supplementation protocols, as its NNMT-inhibition mechanism is distinct from stimulant-based approaches. However, any stacking should be done under medical supervision to assess potential interactions and ensure safety. The non-stimulant nature of the compound may make it compatible with other non-stimulant metabolic support strategies, but individual health status, medications, and existing supplements must be considered.
How long should I run a 5-Amino-1MQ cycle?
Standard cycles last 8-12 weeks, providing sufficient duration to observe meaningful metabolic changes and assess individual tolerance. This timeframe reflects a balance between maximizing the compound's effects and minimizing adaptive resistance. After completing a cycle, many users take a break before beginning another, which helps maintain responsiveness to the compound. The exact cycle length may vary based on individual metabolic response and goals, ideally under medical guidance.
Which lab markers should I monitor while using 5-Amino-1MQ?
Liver enzymes must be monitored, as 5-Amino-1MQ is metabolized hepatically. Baseline bloodwork before starting and periodic assessments throughout the 8-12 week cycle are strongly recommended. Additionally, tracking metabolic markers such as fasting glucose, insulin sensitivity, triglycerides, and lipid panels helps assess the compound's effectiveness and overall safety. Regular monitoring enables early detection of any adverse effects and confirms metabolic improvements.
What is the legal and regulatory status of 5-Amino-1MQ?
5-Amino-1MQ is not FDA-approved for human use and is marketed as a research chemical. Its legal status varies by jurisdiction, and it is typically sold for research purposes only. Users should verify local regulations before purchasing or using the compound. For research purposes only—not FDA-approved for human use. Consult a licensed physician before use. Always obtain proper medical guidance to ensure compliance with local laws and assess suitability for your individual circumstances.
What effects should I expect to feel when taking 5-Amino-1MQ?
Users commonly report increased energy levels, reflecting the compound's metabolic enhancement mechanism. Some experience mild nausea upon initiation, which typically resolves with consistent use and food administration. Sleep disturbances may occur if taken late in the day, which is why morning dosing is emphasized. Most noticeable effects are metabolic rather than stimulant-based, with users observing improvements in energy, body composition, and metabolic rate progression throughout an 8-12 week cycle.
More GLP-1 & Weight Loss peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.